Invest Liverpool City Region
World Famous, Word Leading
Mayor Steve Rotheram is to lead a high-level delegation backed by the British Embassy and the UK’s Department for Business and Trade to forge closer political, trade and cultural links between the Liverpool City Region (LCR) and the Hamburg city state. Over two days of tours, presentations and talks, senior officials, politicians and policy experts …
Sciontec Developments Limited (Sciontec), has announced its latest vision for its first new build development at Liverpool City Council’s flagship development site, Paddington Village. Sciontec, which owns Liverpool Science Park and manages innovative workspace at The Spine, has updated its plans for its eco-trailblazer new build, HEMISPHERE, which will now be home to circa 50,000 …
Some of the UK’s top pandemic scientists will gather this September for a two-day meeting hosted by The Pandemic Institute. The UK Pandemic Sciences Network Meeting will take place on the 5th and 6th September 2023 at the Spine. The UK Pandemic Sciences Network (UKPSN) brings together leading universities and pandemic science research teams to support the delivery of …
Communities across the Liverpool City Region could be set to benefit from over 4,000 new jobs and a multi-million-pound investment in the life sciences sector as part of the UK’s second Investment Zone. The government has today (26 July 2023) launched England’s second Investment Zone in Liverpool City Region, which could unlock £320 million of private investment and deliver 4,000 …
A landmark innovation deal was signed today that paves the way for greater co-operation between two of the world’s most famous port cities. Liverpool City Region Mayor Steve Rotheram signed a Memorandum of Understanding (MOU) with Park Heong-Joon, Mayor of Busan Metropolitan City in South Korea, aimed at enhancing ‘mutual understanding, prosperity and friendship’. The …
The scaling diagnostic development and laboratory service provider expands their UK operations, bringing LSP’s lab occupancy to 100%. Having launched its first permanent UK Laboratory in October 2022 at Liverpool Science Park (LSP), Pierian Biosciences has now signed a lease for a second CAT-2 laboratory within the Sciontec Developments Limited (Sciontec) owned innovation centre. Now …
Beijing, China, MARCH 29, 2023 – Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) Pharmaron announced today that their Liverpool, UK based Gene Therapy CDMO has received a prestigious grant from the UK Government’s Life Sciences Innovation Manufacturing Fund (LSMIF) to expand their viral vector and DNA manufacturing facilities for more than 8,000 sqM. This major …
In a move to strengthen its worldwide footprint, Brinton Pharmaceuticals Ltd today inaugurated its Global Research and Development Centre in the United Kingdom at The Heath Business and Technical Park in Runcorn, Liverpool City Region. The new centre was officially opened during a visit by Nigel Huddleston MP, Minister of State at the Department for …
A specialist unit has opened at the new Royal Liverpool University Hospital which will perform clinical trials aimed at tackling some of the region’s most common diseases. The opening of the new Liverpool Clinical Research Facility (CRF) unit follows a £5.3m funding award from the National Institute for Health Research (NIHR). A significant proportion …
BioGrad is to open the UK’s second largest biobank facility in Liverpool, as part of a £7.6m investment into a new headquarters at Wavertree Technology Park. In collaboration with the University of Leicester, BioGrad biobank has already welcomed up to 261,000 samples from the largest long-Covid study in the UK. Further partnerships with Liverpool Women’s …
An innovative study has been launched at the Royal Liverpool University Hospital to explore how a new antimicrobial coating can protect the NHS by reducing healthcare associated infections (HAIs) HAIs are a risk to patients, visitors and staff, and cover a range of different infections including methicillin-resistant Staphylococcus aureus (MRSA) and Clostridioides difficile (C. difficile). …
Continuing to move through a pipeline of health and life science investment, LYVA Labs, the Liverpool City Region’s innovation commercialisation organisation, has announced its latest investment in emerging biotech, Daresbury Proteins. Continuing to move through a pipeline of health and life science investment, LYVA Labs, the Liverpool City Region’s innovation commercialisation organisation, has announced its …
